Dr. Bender’s primary research interest continues to be on the outcomes of patients with chronic kidney disease (CKD), mostly on peritoneal dialysis (PD). She is studying outcomes in incident PD patients after renal transplant . She is also participating in a study assessing depression in HD patients utilizing laptop connection.
She has a very busy clinical practice and is active in beside teaching of Renal fellows, medical residents and students. She is the Peritoneal Dialysis Director at the Oakand DCI.
- MD, School of Medicine, Aristotelian Univ., Greece, 1981
- Residency, Internal Medicine, Aghia Sophia Hospital, Greece, 1984
- Residency, Transitional Medicine, Lancaster General Hospital, 1986
- Residency, Internal Medicine, Shadyside Hospital, 1989
- Fellowship, Nephrology, University of Pittsburgh, 1991
Education & Training
Bernardini J, Bender FH, Florio T, Sloand J, PalmMoltabano L, Fried L, Piraino B. Randomized Double Blinded Trial of Peritoneal Dialysis Exit Site Mupirocin 2% versus Gentamicin Sulfate 0.1% Cream . J Am Soc Nephrol. 2005; 16: 539-545.
Bernardini J, Florio T, Bender FH, Fried L, Piraino B. Methods to determine drain volumes for peritoneal dialysis clearances. Peritoneal Dialysis International. 2004; 24: 182-185.
Gehr T, Bender F, Fink J, Light P, Elliott K, Shield C, Turner M, Mays C, Parrish J, Armistead N. Improving adequacy of peritoneal dialysis in ESRD Network 5 (Maryland; Washington, DC; Virginia; West Virginia). Advances in Peritoneal Dialysis. 2003; 19: 86-92.
